MEDYTOX
Medytox Investments is a medical aesthetic company that offers product botulinum, toxin product, hyaluronic acid filler medical device. It also offers services such as public information, financial information, stock price information.
MEDYTOX
Industry:
Manufacturing Medical
Founded:
2000-05-02
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Google Universal Analytics Apache Global Site Tag Euro
Current Employees Featured
Hyunho Jung Founder&CEO @ Medytox
Founder&CEO
Founder
Stock Details
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2018-06-18 | Lifesprout | Medytox investment in Seed Round - Lifesprout | 6.5 M USD |
More informations about "Medytox"
About Medytox
Based on integrity and open communication, Medytox is building excellent capacity and system to meet the global standard with commitment and courage. Furthermore, we are endeavoring to …See details»
Medytox, Inc. Announces the Formation of Luvantas …
IRVINE, Calif., Jan. 3, 2024 /PRNewswire/ -- Medytox, Inc. is pleased to announce the formation of Luvantas, Inc. (www.luvantas.com) as its wholly-owned North American subsidiary.See details»
Global Network - Medytox
Medytox is currently exporting products to approximately 60 countries including Japan and Brazil. In addition, we are striving to penetrate the market in the US and European countries in the …See details»
Medytox, Inc. Announces the Formation of Luvantas Subsidiary …
IRVINE, Calif., Jan. 3, 2024 /PRNewswire/ — Medytox, Inc. is pleased to announce the formation of Luvantas, Inc. (www.luvantas.com) as its wholly-owned North American subsidiary. To read …See details»
Medytox, Inc. Announces the Formation of Luvantas Subsidiary …
IRVINE, Calif., Jan. 3, 2024 /PRNewswire/ -- Medytox, Inc. is pleased to announce the formation of Luvantas, Inc. (www.luvantas.com) as its wholly-owned North American subsidiary.See details»
Medytox, Inc. Announces the Formation of Luvantas Subsidiary …
Jan 8, 2024 · Luvantas is working with Medytox to seek approval for the upcoming introduction of NivobotulinumtoxinA to the United States and Canada. A Biological License Application was …See details»
Medytox Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Medy-Tox, Inc. is a biopharmaceutical company that specializes in producing and distributing various products such as botulinum toxin, hyaluronic acid filler, medical devices, toxin …See details»
Medytox, Inc. Announces Executive Appointments in Luvantas, Inc
Jan 3, 2024 · Medytox Inc. announced the formation of Luvantas Inc. as its wholly-owned North American subsidiary. In connection with the formation of Luvantas, Thomas A. Albright has …See details»
Medytox Plants US Base in Irvine - Orange County Business Journal
Jan 15, 2024 · South Korean biopharmaceutical firm Medytox Inc., a neurotoxin manufacturer that previously partnered with local drugmaker Allergan, has formed a new domestic subsidiary …See details»
Medytox - Crunchbase Investor Profile & Investments
Medytox is a medical aesthetic company that offers product botulinum, toxin product, hyaluronic acid filler medical device. Medytox may be growing as the establishment of a US base in Irvine …See details»
History - Medytox
Established Medytox Inc. (May 2nd) 글로벌 바이오제약 기업 메디톡스입니다.See details»
Medytox, Inc. Announces the Formation of Luvantas Subsidiary …
Jan 3, 2024 · Medytox, Inc. is pleased to announce the formation of Luvantas, Inc. (www.luvantas.com) as its wholly-owned North American subsidiary.See details»
Allergan Licenses Rights to Medytox… | American Med Spa …
Jun 25, 2018 · In a deal that could net Medytox up to $362 million, the Seoul-based company will license to Allergan exclusive global rights outside Korea to develop and commercialize …See details»
Medytox | Company Overview & News - Forbes
Medy-Tox, Inc. engages in the manufacture and sale of biopharmaceutical products. Its products include botulinum toxin, hyaluronic acid filler, medical devices, toxin detection kit and...See details»
Medytox | JMP
Korean biopharmaceutical company Medytox is best known for pioneering Neuronox, a botulinum toxin type A (BTX-A)-based product indicated for both aesthetic and medical uses as a …See details»
Medytox - Funding, Financials, Valuation & Investors - Crunchbase
Medytox is a medical aesthetic company that offers product botulinum, toxin product, hyaluronic acid filler medical device.See details»
MT-122 - Drug Targets, Indications, Patents - Synapse
Understand key drug designations in just a few clicks with Synapse. MT-122, Initially developed by Medytox Inc., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Immune …See details»
News - Medytox
Since its establishment in 2000, Medytox has developed and evolved into a global world-class R&D company with the successful launch of its main neurotoxin product.See details»
Botulinum toxin A - AbbVie/Medytox - AdisInsight - Springer
Jul 25, 2024 · If your organization has a subscription, there are several access options, even while working remotely: Working within your organization’s network Login with …See details»
Medy-Tox, Inc. ESG Risk Rating - Sustainalytics
Medy-Tox Inc. is a Korea-based company engaged in the development, manufacture, and marketing of biopharmaceuticals. The company's main product is type-A botulium toxin …See details»